ChoA Pharmaceutical Co.Ltd (034940) — Capital Reinvestment Ratio

Latest as of September 2025: 0.26x

ChoA Pharmaceutical Co.Ltd (034940) has a Capital Reinvestment Ratio of 0.26x as of September 2025, meaning it reinvests 0% of its operating cash flow (₩1.26 Billion) in capital expenditures (₩324.67 Million). Check 034940 goodwill-adjusted equity ratio to evaluate the tangible quality of the company's equity base.

Capital Reinvestment Ratio

0.26x
Capex / Operating Cash Flow

Operating Cash Flow

₩1.26 Billion
KRW

Capital Expenditures

₩324.67 Million
KRW

Data as of

Sep 2025
Most recent filing

ChoA Pharmaceutical Co.Ltd Capital Reinvestment Ratio (2004–2020)

This chart tracks ChoA Pharmaceutical Co.Ltd's Capital Reinvestment Ratio across 8 annual periods. For the full cash flow conversion analysis, see how efficiently does ChoA Pharmaceutical Co.Ltd generate cash.

Annual Capital Reinvestment Ratio for ChoA Pharmaceutical Co.Ltd (2004–2020)

Year-by-year Capital Reinvestment Ratio for ChoA Pharmaceutical Co.Ltd from 2004 to 2020. See 034940 FCF generation index to measure how efficiently the company converts operating cash flow to free cash.

Year Reinvestment Ratio Operating CF (KRW) Capital Expenditures YoY Change
2020 1.87x ₩1.92 Billion ₩3.60 Billion ▲ +460.2%
2019 0.33x ₩4.16 Billion ₩1.39 Billion ▼ -65.4%
2018 0.96x ₩2.04 Billion ₩1.97 Billion ▼ -60.9%
2016 2.47x ₩930.42 Million ₩2.30 Billion ▲ +64.4%
2015 1.50x ₩1.19 Billion ₩1.78 Billion ▼ -83.3%
2014 9.02x ₩625.52 Million ₩5.64 Billion ▲ +2884.8%
2013 0.30x ₩3.53 Billion ₩1.07 Billion ▲ +110.8%
2004 0.14x ₩3.57 Billion ₩512.47 Million
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow